Shalby Ltd.

283.60 +1.90 ▲0.7%

25 April 2024, 04:03:39 PM
Volume: 196,620

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.shalby.org
Market Cap 3,063.16 Cr.
Enterprise Value(EV) 3,166.20 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 7.53 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 37.64 Trailing Twelve Months Ending 2023-12
Industry PE 67.18 Trailing Twelve Months Ending 2023-12
Book Value / Share 91.07 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.11 Calculated using Price: 283.60
Dividend Yield 0.42 Period Ending 2023-03
No. of Shares Subscribed 10.80 Cr. 108,009,770 Shares
FaceValue 10
About Shalby Ltd.
The company is one of the leading multi-specialty chains of hospitals in India. Its hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations.

Shalby Ltd. Delivery

Delivered Qty
Traded Qty

Shalby Ltd. Performance

1 Day
+0.67%
1 Week
+5.23%
1 Month
+16.73%
3 Month
-9.58%
6 Month
+17.77%
1 Year
+95.52%
2 Year
+112.75%
5 Year
+113.63%
10 Year

Shalby Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 15.92 19.5 12.6 7.81 4.13 3.49 5.19 6.31 7.51
Return on Capital Employed (%) 21.84 13.34 12.21 9.15 6.94 7.49 6.85 9.08 10.72
Return on Assets (%) 8.64 8.49 4.61 4.42 3.12 2.72 4.05 4.6 5.06

Shalby Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 168 205 251 751 780 799 835 876 928 964
Non Curr. Liab. 90 207 291 140 130 144 150 234 269 159
Curr. Liab. 90 92 199 138 88 83 82 172 194 193
Minority Int. 2 0 -1 0 0 0 0 0 0 0
Equity & Liab. 351 504 741 1,030 998 1,027 1,066 1,282 1,391 1,316
Non Curr. Assets 289 440 582 794 801 793 795 833 874 760
Curr. Assets 63 64 159 236 197 234 271 442 517 556
Misc. Exp. not W/O
Total Assets 351 504 741 1,030 998 1,027 1,066 1,282 1,391 1,316

Shalby Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 275 290 324 378 462 487 431 699 805 889
Other Income 2 2 7 10 9 17 9 12 23 24
Total Income 278 293 331 388 472 504 440 711 827 912
Total Expenditure -208 -235 -252 -299 -379 -404 -344 -577 -667 -725
PBIDT 70 58 78 89 93 100 96 134 161 187
Interest -5 -10 -11 -12 -9 -7 -5 -8 -11 -12
Depreciation -21 -11 -17 -23 -33 -36 -37 -43 -48 -49
Taxation -18 0 -22 -15 -19 -29 -13 -25 -34 -44
Exceptional Items -4
PAT 25 36 29 39 32 28 42 54 68 81
Minority Interest 1 1 1 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 26 38 30 39 32 28 42 54 68 81
Adjusted EPS 7 4 3 4 3 3 4 5 6 8

Shalby Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 5 123 5 60 14 43 55 79 19 68
Cash Fr. Inv. -26 -62 -98 -153 -237 1 -31 -51 -60 -61
Cash Fr. Finan. 24 -39 75 96 222 -51 -22 -30 90 -50
Net Change 3 22 -19 3 0 -6 3 -2 49 -43
Cash & Cash Eqvt 6 27 9 12 12 5 8 6 56 12

Shalby Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 74.02 74.04 74.04 74.12 74.12 74.12 74.12 74.12 74.24
Public 25.98 25.97 25.97 25.88 25.88 25.88 25.88 25.88 25.76
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Shalby Ltd. Announcements

Thu, 11 Apr 2024
Updates
Shalby Limited has informed the Exchange regarding 'Incorporation of Wholly-owned Subsidiary by Foreign Step-down subsidiary '. - Shalby Advanced Technologies, Inc., USA (Step-down subsidiary of the Company) has incorporated its Wholly-Owned Subsidiary in India under the name and style of Shalby Advanced Technologies India Private Limited on April 11, 2024.
Mon, 08 Apr 2024
Disclosure under SEBI Takeover Regulations
Dr. Vikram Shahᅡᅠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaᅡᅠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ᅡᅠ
Fri, 05 Apr 2024
Updates
Shalby Limited has informed the Exchange regarding 'Intimation for availing of Working Capital Facilities'.

Shalby Ltd. Technical Scans

Wed, 24 Apr 2024
Higher Delivery Quantity Higher Delivery Quantity
Closing Above Previous High Closing Above Previous High
Closing Above Previous High For 3 Days Closing Above Previous High For 3 Days
Making Higher Highs for 3 days Making Higher Highs for 3 days
Closing Above Previous High for 2 Days Closing Above Previous High for 2 Days

Shalby Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,140.18 1,520.15 +2.3%
Cipla Ltd. 112,292.49 1,406.20 +0.6%
Divi's Laboratories Ltd. 101,276.26 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. 99,314.42 6,218.75 +4.5%
Mankind Pharma Ltd. 95,586.41 2,398.55 +0.0%
Zydus Lifesciences Ltd. 93,730.70 951.25 +1.9%
Torrent Pharmaceuticals Ltd. 90,650.92 2,694.30 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.44 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 30.28 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 73.23 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 55.35 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.52 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.68 2,694.30 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.77 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-12 4.34 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.77 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-12 10.76 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.97 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.68 2,694.30 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,694.30 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,694.30 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 +2.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 +0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 +4.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,694.30 +0.3%

Shalby Ltd. FAQ's

What is Shalby share price?

Can I buy Shalby shares now?

What is the Dividend Yield of Shalby?

What is the Market Cap of Shalby?

What are the key metrics to analyse Shalby?

What is the 52 Week High and Low of Shalby?

What is the trend of Shalby share price?